Nalinda B. Wasala

Cas9-specific immune responses compromise local and systemic AAV CRISPR therapy in multiple dystrophic canine models

Chady H. Hakim, Sandeep Kumar, Dennis O. Pérez‐López et al. · Nature Communications · 2021 · 170 citations · Full text

Life Sciences, Immunology, Molecular Genetics +16

A Five-Repeat Micro-Dystrophin Gene Ameliorated Dystrophic Phenotype in the Severe DBA/2J-mdx Model of Duchenne Muscular Dystrophy

Chady H. Hakim, Nalinda B. Wasala, Xiufang Pan et al. · Molecular Therapy — Methods & Clinical Development · 2017 · 109 citations · Full text

Medicine, Genetics, Molecular Genetics +11

AAV CRISPR editing rescues cardiac and muscle function for 18 months in dystrophic mice

Chady H. Hakim, Nalinda B. Wasala, Christopher E. Nelson et al. · JCI Insight · 2018 · 99 citations · Full text

Life Sciences, Genetics, Molecular Biology +15

AAV micro-dystrophin gene therapy alleviates stress-induced cardiac death but not myocardial fibrosis in > 21-m-old mdx mice, an end-stage model of Duchenne muscular dystrophy cardiomyopathy

Jin‐Hong Shin, Yongping Yue, Nalinda B. Wasala et al. · Journal of Molecular and Cellular Cardiology · 2012 · 79 citations · Full text

Medicine, Cardiology, Molecular Genetics +12

Evaluation of Muscle Function of the Extensor Digitorum Longus Muscle <em>Ex vivo</em> and Tibialis Anterior Muscle <em>In situ</em> in Mice

Chady H. Hakim, Nalinda B. Wasala, Dongsheng Duan · Journal of Visualized Experiments · 2013 · 75 citations

Life Sciences, Anatomy, Physiology +17